This
page
is
part
of
the
Continuous
Integration
Build
of
FHIR
Specification
(v5.0.0:
R5
-
STU
).
This
is
the
current
published
version
in
it's
permanent
home
(it
will
always
(will
be
available
incorrect/inconsistent
at
this
URL).
For
a
full
list
of
available
versions,
see
times).
See
the
Directory
of
published
versions
.
Page
versions:
R5
R4B
R4
R3
| Responsible Owner: Pharmacy Work Group | Standards Status : Informative | Compartments : Encounter , Group , Patient |
This is the narrative for the resource. See also the XML , JSON or Turtle format. This example conforms to the profile MedicationAdministration .
Generated Narrative: MedicationAdministration medadmin0304
status
:
completed
Completed
| Reference |
|
Medication
alemtuzumab
10
MG/ML
[Lemtrada]
|
subject
:
Patient/pat1:
Donald
Duck
"Donald
DUCK"
encounter
:
Encounter/f001:
encounter
who
leads
to
this
prescription
occurence
occurrence
:
2015-01-15T04:30:00+01:00
-->
2015-01-15T14:30:00+01:00
performer
Actors
Reference Practitioner/f007:Patrick Pump"Simone HEPS"
| Reference |
|
|
| Text | Route | Method | Dose |
| Rapid daily-dose escalation, until tolerated, from 3 mg/d, and then 10 mg/d, to the recommended maintenance dose of 30 mg IV over 120 min, 3 times per wk on alternate days for up to 12 wk |
Intravenous
route
|
Inject
-
dosing
instruction
imperative
(qualifier
value)
|
3
mg
(Details:
UCUM
|
Generated Narrative: Medication #med0303
code : alemtuzumab 10 MG/ML [Lemtrada]
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.